About this trial

Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.

Eligibility criteria

Qualifiers

Patients candidate to WB-MRI according to clinical practice belonging to the study groups listed above.

Participant is willing and able to give informed consent for participation in the study.

Male or Female, aged ≥ 18 years.

Life expectancy greater than 3 months.

Disqualifiers

Patients with MRI-unsafe prostheses and devices.

Patients whose tests are of suboptimal quality, or whose test has been suspended, or is incomplete.

Trial design

Treatments tested in this trial

  • Whole Body-Magnetic Resonance Imaging (WB-MRI)

Treatment groups

1,000 Participants
are divided into 3 treatment groups

Locations

3
IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. Orsola40138, BolognaBO, Italy
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l.47014, MeldolaFC, Italy
IRCCS Istituto Europeo di Oncologia S.r.l.20141, MilanMI, Italy

Sponsors and collaborators

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Lead sponsor